Create a Free Account
or
AMRZ Amrize Ltd
NYSE www.holcim.com/investors/listing-north-america-business-us
$ 47.93 $ -0.76 (-1.56 %)
Monday, 17-Nov-2025 15:47:28 EST
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 10-29-2025 | 09-30-2025 | 10-Q | |
| 2 | 08-07-2025 | 06-30-2025 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Stephens & Co. analyst Trey Grooms initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price...
UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $52 to $53.
Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and raises the price target from $60 to $63.
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $57 to $58.
Amrize (NYSE:AMRZ) raises FY2025 sales outlook from $11.400 billion-$11.800 billion to $11.700 billion-$12.000 billion vs $11.7...
Amrize (NYSE:AMRZ) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.00 by 2 per...
UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $49 to $52.
Wells Fargo analyst Timna Tanners initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Targ...
